DEWA Organises Virtual WETEX and Dubai Solar Show From 26-28 October 2020
Dubai Electricity and Water Authority (DEWA) will organise the 22nd Water, Energy, Technology and Environment Exhibition (WETEX) and the 5th Dubai Solar Show virtually from 26-28 October 2020. The two exhibitions will provide a new experience for exhibitors to display their products innovatively, through 3D customisable stands to suit each company’s needs. They also will enable meetings, seminars, and workshops using the latest smart technologies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200916005413/en/
WETEX and Dubai Solar Show, First Ever Carbon Neutral 3D Virtual Exhibition (Photo: AETOSWire)
“For 21 years, WETEX has established its position as one of the largest and most important global water, environment, and energy exhibitions. From our wise leadership, we have learned the importance of turning challenges into opportunities. Due to the precautionary measures implemented in most countries because of COVID-19, WETEX and the Dubai Solar Show 2020 will happen virtually; using DEWA’s state-of-the-art digital infrastructure. This will provide an exceptional experience for exhibitors to reach a larger number of visitors across the world,” said HE Saeed Mohammed Al Tayer, MD & CEO of DEWA, and Founder and Chairman of WETEX and Dubai Solar Show.
Al Tayer explained that WETEX and the Dubai Solar Show provide an outstanding opportunity for public and private companies to reach thousands of participants, officials, and decision-makers in energy, water, renewable energy, environment, and sustainability. They will be able to make deals, build partnerships, and learn about market needs, especially given the increased adoption of solar photovoltaic technology in the UAE and the region.
Dr Yousef Al Akraf, EVP of Business Support and Human Resources of DEWA, and Head of the Sales, Logistics and Sponsorship Committees at WETEX, said that this year’s exhibition is an important opportunity to learn about the latest smart technologies and innovative solutions in renewable energy, water, and sustainability. It will enable visitors to participate in specialised seminars and workshops to meet global experts on the green economy, smart cities, innovation, and sustainable development. He noted that WETEX and the Dubai Solar Show 2019 attracted 2,350 exhibitors and 38,718 visitors from 89 countries.
For more information about WETEX and the Dubai Solar Show, please visit www.wetex.ae.
*Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200916005413/en/
Contact information
Dubai Electricity and Water Authority
Khuloud Al Ali, +971563974965
Media@dewa.gov.ae
Shaikha Almheiri, +971552288228
Shaikha.almheiri@dewa.gov.ae
Mohammad Almheiri, +971552725291
Mohammad.almheiri@dewa.gov.ae
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release
Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom